What is KPV?
Anti-inflammatory tripeptide derived from alpha-MSH.
KPV is a tripeptide fragment of alpha-melanocyte stimulating hormone (alpha-MSH) with anti-inflammatory properties. Studied for gut inflammation. Very limited human clinical data.
What the evidence says
The overall evidence grade for KPV is C (limited — early or preliminary data, mostly mechanistic or animal). Interesting mechanism but very limited human data.
Specific findings with supporting evidence:
- Shows anti-inflammatory effects in research. Evidence grade C.
- Studied for gut inflammation. Evidence grade C.
Best-supported outcomes:
- Research interest only.
Where marketing outpaces evidence:
- The claim that "Proven in human clinical trials" is not supported by the evidence (grade C).
- Marketing often overstates: Cures gut issues.
- Marketing often overstates: Proven anti-inflammatory.
Dose and timing
Take it in the morning. Research compound only.
Who it's for, and who should skip it
Most relevant for:
- Research interest only.
Not appropriate for:
- Those with gut issues seeking treatment.
Safety and cautions
Important: Very limited data. Human clinical evidence is minimal. Important: Not FDA approved. Research compound.
Common mistakes
- Using for gut treatment.
- Expecting proven anti-inflammatory effects.
Myths vs reality
A common misconception: KPV is proven for gut inflammation. In reality, human clinical data is very limited.
How it interacts with other compounds
- KPV works well alongside bpc 157 — both studied for gut applications.
Questions people ask
Is KPV the same as BPC-157 for gut health? Different mechanisms. Both have limited human data for gut applications.
Editorial note
This guide summarizes the published evidence on KPV. It is educational content, not medical advice. Confirm with your clinician if you take prescription medications or manage a chronic condition.